Fulgent Genetics, Inc. (FLGT) Tops Q1 EPS by 30c

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q1 EPS of ($0.22), $0.30 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $66.2 million versus the consensus estimate of $59.62 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Darling Ingredients (DAR) PT Raised to $88 at UBS
• AI and earnings keep driving markets as focus shifts to Trump-Xi summit